Product Description
Mabvinra 40mg Injection is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get the maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better.
Some of the common side effects of this medicine include headache, sinus inflammation, rash upper respiratory tract infection, and injection site reactions such as pain, redness, and swelling. Talk to your doctor if any of these side effects do not go away with time or get worse. Your doctor may help with ways to reduce or prevent these symptoms.
To make sure the medicine is safe for you, before taking it, let your doctor know if you have any problems with your heart, kidneys, or liver. You should also tell your doctor about all the other medicines you are taking. It is important for pregnant and breastfeeding women to ask the advice of their doctors before taking this medicine.
How Mabvinra WorksMabvinra contains Adalimumab, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-), a protein associated with inflammation in autoimmune diseases. By blocking this protein, Mabvinra helps reduce inflammation, relieve symptoms, and prevent further joint or tissue damage in various chronic inflammatory conditions.
Administration and Dosage GuidelinesThis medication must be administered as a subcutaneous injection, typically into the thigh, abdomen, or upper arm. Dosage and frequency are determined by your physician based on your specific medical condition. The injection should only be used if the solution is clear and free from particles, as per the included safety precautions.
Storage and Safety PrecautionsKeep Mabvinra refrigerated between 2C and 8C, and never freeze the injection. Check the medication before use and do not administer if the solution appears cloudy, discolored, or contains particles. Use within its expiry period, and always keep the medication out of reach of children. Refer to the included patient leaflet for complete usage and safety instructions.
FAQ's of Mabvinra Adalimumab 40 Mg Injection:
Q: How should I use Mabvinra Adalimumab 40 Mg Injection?
A: Mabvinra should be injected subcutaneously, as instructed by your physician. The recommended injection sites are the thigh, abdomen, or upper arm. Follow the exact dosage and schedule prescribed, and always refer to the patient information leaflet for detailed guidance.
Q: What conditions is Mabvinra prescribed for?
A: Mabvinra is used to treat autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, and juvenile idiopathic arthritis in adults and children as advised by a healthcare professional.
Q: When should I not use this injection?
A: Do not use Mabvinra if the solution is cloudy, discolored, or contains particles. It is essential to check the expiry date and consult your doctor before each administration. Always use the medicine under medical supervision and upon prescription.
Q: Where should Mabvinra be stored?
A: Store Mabvinra in a refrigerator at 2C to 8C, making sure you avoid freezing it. Keep the injection away from children and avoid exposure to direct sunlight or excessive heat.
Q: What are the possible side effects of Mabvinra?
A: Common side effects may include injection site reactions, upper respiratory infections, headache, and rash. For a comprehensive list of side effects and risk information, refer to the patient information leaflet provided in the package.
Q: What benefits can I expect from using Mabvinra?
A: Mabvinra is effective in reducing inflammation, relieving symptoms, and slowing disease progression in various autoimmune conditions, leading to improved mobility and quality of life as part of comprehensive medical management.